Pediatric Allergic Rhinitis: When Meds Fall Short - Takeaway - MDSpire
From the Journals

Pediatric Allergic Rhinitis: When Meds Fall Short

Prospective cohort compares surgical vs medical management in refractory pediatric disease.

Share

  • 1

    Inferior turbinate reduction effectively improves sinonasal symptoms in children.

  • 2

    Study participants aged 5 to 17 years had refractory allergic rhinitis.

  • 3

    Greater reductions in symptom scores were observed post-surgery.

  • 4

    88% of surgery patients experienced complete disease regression at 1 month.

  • 5

    Outcomes relied on patient-reported questionnaires.

  • 6

    Small sample size and non-randomized allocation may affect results.

  • 7

    Key author: Jad Hosri from American University of Beirut Medical Center.

Original Source(s)

Pediatric Allergic Rhinitis: When Meds Fall Short

  • by Kathryn Wighton

  • April 9, 2026

Related Content

First and only center in Arizona to receive highest designation for advanced life support

Phoenix Children’s has been recognized with the prestigious ELSO Award for Excellence in Life Support, achieving Platinum Center of Excellence status from the Extracorporeal Life Support Organization (ELSO).

  • by

  • April 9, 2026

  • 4 min
Recognition and Management of Metabolic Epilepsies

This video presents a clinically grounded overview of recent advances in neurogenetics and precision-based therapies for severe childhood-onset neurological disorders, including Dravet syndrome and related epileptic encephalopathies

  • April 7, 2026

Rett Syndrome - a Multidisciplinary Approach

This presentation by Dr. Terry Grebe and Dr. Venode Narayanan outlines the multidisciplinary clinical management of Rett Syndrome (a neurodevelopmental disorder typically linked to MECP2 mutations) and explores emerging research, including the FDA-approved treatment trofinetide and experimental gene editing therapies.

  • April 7, 2026